Heteroaromatic inhibitors of fructose 1,6-bisphosphatase
US7312219B2 · kind B2 · utility
4Cited by
36References
145Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2003 |
| Grant date | Dec 25, 2007 |
| Priority date | — |
| Expiry date | Aug 6, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65846
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel FBPase inhibitors of the formula I and Xare useful in the treatment of diabetes and other conditions associated with elevated blood glucose.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.